Damora Therapeutics
DMRA
20.24
+0.69
+3.53%
Damora Therapeutics
US · DMRA
#3109 by market cap
Listed 1970
20.24
+0.69
+3.53%
Live - 5344 symbols - heartbeat 93s ago
· 2026-10-07 19:54
After-hours
20.24
0.00%
- Market cap
- 1.25B
- P/E (TTM)i
- -77.85
- P/Bi
- 3.24
- EPSi
- -3.98
- Div yieldi
- 0.00%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on DMRA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
46.67 +130.6%
Price target rangecurrent 20.24
Low40.00
Avg46.67
High60.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Wedbush | -- | BUY | 40.00 |
| 2026-09-24 | Guggenheim | -- | BUY | 60.00 |
| 2026-09-18 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-08-11 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-08-11 | Wedbush | -- | BUY | 40.00 |
| 2026-08-11 | Jefferies | -- | BUY | 50.00 |
| 2026-08-11 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-08-10 | TD Cowen | -- | BUY | -- |
| 2026-08-10 | RBC Capital | -- | BUY | 40.00 |
| 2026-08-06 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-08-06 | Wedbush | -- | BUY | 40.00 |
| 2026-08-05 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-07-30 | Wedbush | -- | BUY | 40.00 |
| 2026-07-26 | Jefferies | -- | BUY | 50.00 |
| 2026-07-21 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-06-30 | RBC Capital | -- | BUY | 40.00 |
| 2026-06-22 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-06-16 | Wedbush | -- | BUY | 35.00 |
| 2026-06-15 | Guggenheim | -- | BUY | 40.00 |
| 2026-06-12 | Wedbush | -- | BUY | 35.00 |
| 2026-06-11 | TD Cowen | -- | BUY | -- |
| 2026-06-11 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-06-08 | TD Cowen | -- | BUY | -- |
| 2026-05-28 | Wedbush | -- | BUY | 35.00 |
| 2026-05-16 | LifeSci Capital | -- | BUY | 45.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.